Results 131 to 140 of about 19,843 (235)

Changes in Ventilatory Support Requirements of Spinal Muscular Atrophy (SMA) Patients Post Gene-Based Therapies. [PDF]

Children (Basel), 2022
Panagiotou P, Kanaka-Gantenbein C, Kaditis AG.   +2 more
europepmc   +1 more source

V. Spinal and Bulbar Muscular Atrophy (SBMA) and Bulbar Muscular Atrophy (SMA)

Nihon Naika Gakkai Zasshi, 2022
Shinichiro Yamada, Tomoki Hirunagi, Kentaro Sahashi, Masahisa Katsuno   +3 more
openaire   +1 more source

Proximal spinal muscular atrophy: current orthopedic perspective

The Application of Clinical Genetics, 2013
Gerrit Haaker, Albert Fujak Department of Orthopaedic Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Abstract: Spinal muscular atrophy (SMA) is a hereditary neuromuscular disease of lower motor neurons that is ...
Haaker G, Fujak A
doaj  

Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA). [PDF]

Pharmacoeconomics, 2022
Paracha N, Hudson P, Mitchell S, Sutherland CS.   +3 more
europepmc   +1 more source

Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). [PDF]

J Neurol, 2023
Oskoui M, Day JW, Deconinck N, Mazzone ES, Nascimento A, Saito K, Vuillerot C, Baranello G, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Papp G, Gorni K, Kletzl H, Martin C, McIver T, Scalco RS, Staunton H, Yeung WY, Fontoura P, Mercuri E, SUNFISH Working Group.   +22 more
europepmc   +1 more source

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol. [PDF]

BMC Neurol, 2023
Ros LAA, Goedee HS, Franssen H, Asselman FL, Bartels B, Cuppen I, van Eijk RPA, Sleutjes BTHM, van der Pol WL, Wadman RI.   +9 more
europepmc   +1 more source

Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA). [PDF]

Pharmacoeconomics, 2022
Paracha N, Hudson P, Mitchell S, Sutherland CS.   +3 more
europepmc   +1 more source

Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers. [PDF]

Pharmacoeconomics, 2022
Sutherland CS, Hudson P, Mitchell S, Paracha N.   +3 more
europepmc   +1 more source

Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada. [PDF]

J Neuromuscul Dis, 2021
McMillan HJ, Gerber B, Cowling T, Khuu W, Mayer M, Wu JW, Maturi B, Klein-Panneton K, Cabalteja C, Lochmüller H.   +9 more
europepmc   +1 more source

Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review. [PDF]

Int J Mol Sci, 2021
Chong LC, Gandhi G, Lee JM, Yeo WWY, Choi SB.   +4 more
europepmc   +1 more source